We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Medesis Pharma souhaite accélérer le développement de ses produits antinucléaires et fait un point sur sa stratégie Medesis Pharma souhaite accélérer le développement de ses produits...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.089 | -20.7459207459 | 0.429 | 0.429 | 0.307 | 58103 | 0.35829903 | DE |
4 | -0.129 | -27.5053304904 | 0.469 | 0.518 | 0.307 | 38411 | 0.39937585 | DE |
12 | -0.32 | -48.4848484848 | 0.66 | 0.708 | 0.307 | 47492 | 0.4497981 | DE |
26 | -0.612 | -64.2857142857 | 0.952 | 2 | 0.307 | 43726 | 0.71903368 | DE |
52 | -0.502 | -59.6199524941 | 0.842 | 2.4 | 0.307 | 25924 | 0.80653395 | DE |
156 | -4.9 | -93.5114503817 | 5.24 | 7.16 | 0.307 | 11716 | 1.65227239 | DE |
260 | -12.16 | -97.28 | 12.5 | 18 | 0.307 | 12261 | 3.98357867 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions